Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels

PURPOSE: Prostate-specific antigen (PSA) is a surrogate marker of disease progression; however, its predictive ability in the extreme ranges is unknown. We determined the predictors of survival in patients with bone metastatic prostate cancer (BMPCa) and with extremely high PSA levels. METHODS: Trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Kyo Chul, Park, Sang Un, Kim, Ki Hong, Rha, Koon Ho, Hong, Sung Joon, Yang, Seung Choul, Chung, Byung Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494633/
https://www.ncbi.nlm.nih.gov/pubmed/26157761
http://dx.doi.org/10.1016/j.prnil.2015.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494633/
https://www.ncbi.nlm.nih.gov/pubmed/26157761
http://dx.doi.org/10.1016/j.prnil.2015.02.006

Ejemplares similares